I have to concede that I feel lost. Lost in the corruption of the FDA. I feel that nothing good happens with the FDA.
The entire sector turned down heavily back when Hillary got on her soapbox and targeted the pharma sector. It has been almost straight down ever since. Go back and look at the chart and look when Hillary came out against the sector.
Harry, I have already lost more on this stock than you will ever have invested in it. I pray to God it will get approved but the FDA simply won't do it. Additionally, I never thought SRPT would ever be in the $11/share range even if it were flat denied outright, so I was wrong in thinking it would get approved and wrong about the share valuation.
I am not, never have, and never will short this stock. You can pretend what you want if it makes you feel better. That's what most of us longs were doing all along as we ignored the small number of patients and the repeated delays filing with the FDA.
All this talk about what will be price be when they get AA etc. is nice but a little scary. The FDA won't approve the drug even though they should. Let me say that again, the FDA should approve the drug. They just won't.
I wonder if they will change the name of the FDA to the FMA (Federal Mafia Agency)?
They are as crooked as it gets.
So you have been in this stock for 14 years, so you got in around 2002 at about $55/share and now it is at $12 giving you a 14-year return on investment of -75%.
And you're giving advice?
No surprise since the upcoming Adcom is a binary event. Uncertainty makes for volatility and if they time it right in a short term play, they can make a few bucks. The risk reward ratio isn't there though, not by a long shot.
Between the politicians running their mouths, the FED trying to artificially raise rates even though there is nothing in the economy driving it, just because they think the economy can tolerate it, the terrorist strikes, etc., this market is fully and completely broken.
It doesn't work.
I sent CNBC an e-mail about the error, claiming PTCT was down because of the unfavorable Adcom with the FDA; when it was really the BMRN Adcom and nothing to do with PTCT, but they have done nothing about it.
I got some 2-bit response from a Customer Care Representative named Alicia, but it is clear CNBC cares nothing about quality or accuracy.
This stock should be over $50 right now and this is a great chance to get in low while the stock is artificially repressed. Major catalysts coming in the next month include updated NDA filing with the FDA then EMA, followed by dull EMA approval, then favorable Adcom wig the US FDA, then approval by the FDA. Next six mo the should cause this stock to quadruple, maybe even go up 6x from present levels.